Skip to main content
GrowthEst. 2012

Greenoaks Capital

3 AI companies in their portfolio

🇺🇸USA·Neil Mehta

$15B

Awaira Score

out of 100

AI, Enterprise, Consumer is where Greenoaks Capital places their bets. They typically invest at the Growth stage. With $15B under management, they've got the firepower to write big checks. They've backed 3 AI companies so far.

Investment Strategy Analysis

Greenoaks Capital deploys capital from USA with a clear mandate in AI, Enterprise, Consumer. The firm primarily targets Growth opportunities, positioning it to capture value at a specific inflection point in company growth. Managing $15B across 3 known investments suggests a concentrated, high-conviction approach to AI investing. The firm holds a solid position among tracked AI investors, with room to grow its footprint in the ecosystem.

Score

77/100

AUM

$15B

Portfolio Size

3

Founded

2012

Stage Focus

Growth

Country

🇺🇸 USA

$15B

Total capital managed

3

Companies backed

Growth

Preferred investment stage

Sum of all tracked company valuations

$9.3B

AIEnterpriseConsumer

About Greenoaks Capital

Greenoaks Capital is a growth-stage investment firm founded in 2012, headquartered in USA, managing approximately $15B in assets under management. The firm concentrates on AI, Enterprise, Consumer, deploying capital primarily at the growth level. Notable AI portfolio companies include Coupang, Brex, Databricks. Greenoaks Capital has participated in 6 funding rounds tracked by Awaira, deploying capital across AI, Enterprise, Consumer sectors. The firm's investment strategy emphasizes enterprise software and B2B AI applications. Awaira assigns Greenoaks Capital an investor score of 77/100 based on portfolio strength, AI sector exposure, and market activity. The firm investment thesis centers on identifying AI companies that demonstrate strong technical moats, clear paths to revenue, and potential for category leadership within their respective segments. Greenoaks Capital evaluates opportunities based on team quality, market timing, technology differentiation, and capital efficiency. Portfolio companies including Coupang, Brex, Databricks reflect the firm emphasis on backing founders who combine deep technical expertise with commercial execution capability.

Founded: 2012

AI Dev Tools
2

Portfolio Metrics

Companies

2

Categories

1

Top Sector

AI Dev Tools (2)

Avg Score

81/100

Sapphire Ventures (4)Lightspeed Venture Partners (2)NEA (2)Sovereign Wealth Fund (2)

Rounds Led(2)

Series CLead Investor

Feb 2022

$100M

Series DLead Investor

Nov 2021

$210M

Greenoaks Capital is a growth-stage investment firm founded in 2012, headquartered in USA, managing approximately $15B in assets under management. The firm concentrates on AI, Enterprise, Consumer, deploying capital primarily at the growth level. Notable AI portfolio companies include Coupang, Brex, Databricks. Greenoaks Capital has participated in 6 funding rounds tracked by Awaira, deploying capital across AI, Enterprise, Consumer sectors. The firm's investment strategy emphasizes enterprise software and B2B AI applications. Awaira assigns Greenoaks Capital an investor score of 77/100 based on portfolio strength, AI sector exposure, and market activity. The firm investment thesis centers on identifying AI companies that demonstrate strong technical moats, clear paths to revenue, and potential for category leadership within their respective segments. Greenoaks Capital evaluates opportunities based on team quality, market timing, technology differentiation, and capital efficiency. Portfolio companies including Coupang, Brex, Databricks reflect the firm emphasis on backing founders who combine deep technical expertise with commercial execution capability.

Neil Mehta

Investment Track Record

AUM

$15B

Notable Deal

Greenoaks Capital is a growth-stage investment fir...

Founded

2012

Stage

Growth

Greenoaks Capital manages $15B, deploying capital with conviction into AI opportunities that match their thesis.

Frequently Asked Questions

What is Greenoaks Capital's AUM?
The firm manages around $15B. That capital backs Greenoaks Capital's thesis across AI companies — from early-stage rounds through growth-stage follow-ons.
What sectors does Greenoaks Capital focus on?
Greenoaks Capital concentrates on AI, Enterprise, Consumer. That focus has shaped a portfolio of companies building at the intersection of these areas.
How many portfolio companies does Greenoaks Capital have?
Greenoaks Capital has backed at least 3 AI companies that Awaira tracks. Venture portfolios often include undisclosed bets, so the true count could be larger.
What stage does Greenoaks Capital invest in?
Most of Greenoaks Capital's capital goes into Growth rounds. This stage preference aligns with their fund structure and return expectations.
What is Greenoaks Capital's most notable investment?
Among Greenoaks Capital's portfolio, the standout deal is Greenoaks Capital is a growth-stage investment firm founded in 2012, headquartered in USA, managing approximately $15B in assets under management. The firm concentrates on AI, Enterprise, Consumer, deploying capital primarily at the growth level. Notable AI portfolio companies include Coupang, Brex, Databricks. Greenoaks Capital has participated in 6 funding rounds tracked by Awaira, deploying capital across AI, Enterprise, Consumer sectors. The firm's investment strategy emphasizes enterprise software and B2B AI applications. Awaira assigns Greenoaks Capital an investor score of 77/100 based on portfolio strength, AI sector exposure, and market activity. The firm investment thesis centers on identifying AI companies that demonstrate strong technical moats, clear paths to revenue, and potential for category leadership within their respective segments. Greenoaks Capital evaluates opportunities based on team quality, market timing, technology differentiation, and capital efficiency. Portfolio companies including Coupang, Brex, Databricks reflect the firm emphasis on backing founders who combine deep technical expertise with commercial execution capability.. This investment reflects the firm's broader strategy and risk appetite in the AI market.